120 related articles for article (PubMed ID: 15521845)
1. A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn.
Rodriguez-Stanley S; Ciociola AA; Zubaidi S; Proskin HM; Miner PB
Aliment Pharmacol Ther; 2004 Nov; 20(9):975-82. PubMed ID: 15521845
[TBL] [Abstract][Full Text] [Related]
2. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
[TBL] [Abstract][Full Text] [Related]
3. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
Kahrilas PJ; Fennerty MB; Joelsson B
Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
[TBL] [Abstract][Full Text] [Related]
4. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
Vakil N; Guda N; Partington S
Aliment Pharmacol Ther; 2006 Mar; 23(5):649-53. PubMed ID: 16480404
[TBL] [Abstract][Full Text] [Related]
5. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
6. Oesophageal function after oral ranitidine: an acute double blind study in normal subjects.
Baldi F; Ferrarini F; Balestra R; Borioni D; Brunetti G; Barbara L
Hepatogastroenterology; 1984 Feb; 31(1):38-40. PubMed ID: 6321311
[TBL] [Abstract][Full Text] [Related]
7. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
[TBL] [Abstract][Full Text] [Related]
9. Influence of intra-oesophageal capsaicin instillation on heartburn induction and oesophageal sensitivity in man.
Kindt S; Vos R; Blondeau K; Tack J
Neurogastroenterol Motil; 2009 Oct; 21(10):1032-e82. PubMed ID: 19566590
[TBL] [Abstract][Full Text] [Related]
10. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
Pipkin GA; Mills JG
Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
[TBL] [Abstract][Full Text] [Related]
11. Effect of ranitidine on gastric acid and pepsin secretion following sham feeding.
Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
Scand J Gastroenterol Suppl; 1981 Jun; 69():27-31. PubMed ID: 6119779
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
13. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
[TBL] [Abstract][Full Text] [Related]
14. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
Holtmeier W; Holtmann G; Caspary WF; Weingärtner U
J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
[TBL] [Abstract][Full Text] [Related]
15. Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn.
Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
Aliment Pharmacol Ther; 2001 Sep; 15(9):1365-74. PubMed ID: 11552907
[TBL] [Abstract][Full Text] [Related]
16. Single dose oral ranitidine improves MRCP image quality: a double-blind study.
Bowes MT; Martin DF; Melling A; Roberts D; Laasch HU; Sukumar S; Morris J
Clin Radiol; 2007 Jan; 62(1):53-7. PubMed ID: 17145264
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of increasing doses of ranitidine for treatment of heartburn.
Pappa KA; Buaron K; Payne JE; Sirgo MA; Giefer EE
Aliment Pharmacol Ther; 1999 Apr; 13(4):475-81. PubMed ID: 10215731
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study of the effectiveness and safety of nizatidine in the prevention of postprandial heartburn.
Spiegel JE; Thoden WR; Pappas K; Fratarcangelo P; Furey SA
Arch Intern Med; 1997 Jul; 157(14):1594-9. PubMed ID: 9236562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
